SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
1-Year Return
18.59%
This Quarter Return
+20.08%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.37B
AUM Growth
+$183M
(+8.4%)
Cap. Flow
-$178M
Cap. Flow
% of AUM
-7.51%
Top 10 Holdings %
Top 10 Hldgs %
42.39%
Holding
113
New
23
Increased
16
Reduced
30
Closed
11
Top Buys
| 1 |
Coca-Cola
KO
|
$33.4M |
| 2 |
Apple
AAPL
|
$30.3M |
| 3 |
CRH
CRH
|
$28.9M |
| 4 |
ArriVent BioPharma
AVBP
|
$27.9M |
| 5 |
argenx
ARGX
|
$26.9M |
Top Sells
| 1 |
Arcellx
ACLX
|
$60.8M |
| 2 |
Royalty Pharma
RPRX
|
$49.7M |
| 3 |
Las Vegas Sands
LVS
|
$36.3M |
| 4 |
Microsoft
MSFT
|
$34.8M |
| 5 |
Biohaven
BHVN
|
$31.2M |
Sector Composition
| 1 | Healthcare | 65.84% |
| 2 | Technology | 8.92% |
| 3 | Communication Services | 8% |
| 4 | Consumer Discretionary | 5.07% |
| 5 | Financials | 3.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MOLN
76
Molecular Partners
MOLN
$133M
| $1.68M | 0.06% |
400,000
| – | – |
|
77
Stryker
SYK
$151B
| $1.56M | 0.06% |
4,360
| – | – |
|
78
Medtronic
MDT
$119B
| $1.52M | 0.06% |
17,460
| – | – |
|
79
Galapagos
GLPG
$2.1B
| $1.52M | 0.06% |
47,200
| – | – |
|
80
CVS Health
CVS
$93.5B
| $1.37M | 0.05% |
17,170
| – | – |
|
81
Illumina
ILMN
$15.5B
| $1.2M | 0.04% |
8,974
| – | – |
|
|
AKLI
82
DELISTED
Akili, Inc. Common Stock
AKLI
| $1.11M | 0.04% |
3,841,718
| – | – |
|
83
Waters Corp
WAT
$17.8B
| $1.08M | 0.04% |
3,150
| – | – |
|
84
Benitec Biopharma
BNTC
$368M
| $1.07M | 0.04% |
204,220
| – | – |
|
85
HCA Healthcare
HCA
$96.3B
| $1.06M | 0.04% |
+3,190
| New | +$1.06M |
|
86
Edwards Lifesciences
EW
$47.5B
| $1.06M | 0.04% |
+11,100
| New | +$1.06M |
|
87
Protagonist Therapeutics
PTGX
$3.71B
| $882K | 0.03% |
+30,500
| New | +$882K |
|
88
DexCom
DXCM
$31.7B
| $816K | 0.03% |
5,880
| – | – |
|
89
Agilent Technologies
A
$36.4B
| $726K | 0.03% |
4,990
| – | – |
|
90
Morgan Stanley
MS
$240B
| $719K | 0.03% |
7,641
+2,841
| +59% | +$268K |
|
91
Humana
HUM
$37.5B
| $676K | 0.03% |
+1,950
| New | +$676K |
|
92
Veralto
VLTO
$26.5B
| $485K | 0.02% |
5,475
| – | – |
|
93
ResMed
RMD
$40.1B
| $473K | 0.02% |
+2,390
| New | +$473K |
|
94
Ionis Pharmaceuticals
IONS
$9.46B
| $468K | 0.02% |
+10,800
| New | +$468K |
|
95
Zimmer Biomet
ZBH
$20.8B
| $430K | 0.02% |
+3,260
| New | +$430K |
|
96
Align Technology
ALGN
$9.76B
| $361K | 0.01% |
+1,100
| New | +$361K |
|
97
Steris
STE
$24B
| $344K | 0.01% |
+1,530
| New | +$344K |
|
98
Baxter International
BAX
$12.1B
| $341K | 0.01% |
+7,970
| New | +$341K |
|
99
Charles River Laboratories
CRL
$7.99B
| $274K | 0.01% |
1,010
| – | – |
|
100
Agios Pharmaceuticals
AGIO
$2.1B
| – | – |
-399,451
| Closed | -$8.9M |
|